Qingqing Wang
Impact in
- Microbiology top 5%
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
- Oncology 10
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- Yumeng Yao (4 shared papers)Bijie Hu (6 shared papers)Sisi Chen (1 shared paper)Kai Liu (1 shared paper)Qingfeng Shi (2 shared papers)Kaihuan Yu (1 shared paper)Xiang Chen (1 shared paper)Zheyong Huang (1 shared paper)
- Journals
- Acta Pharmacologica Sinica (2 papers)Clinical Infectious Diseases (1 paper)Frontiers in Immunology (1 paper)Environmental Pollution (1 paper)Annals of Translational Medicine (1 paper)
- Partner nations
- ChinaUnited StatesCzechia
In The Last Decade
Qingqing Wang
42 papers receiving 1.5k citations
Qingqing Wang's Hit Papers
Peers
Comparison fields: 5 of 119
- Microbiology 31
- Infectious Diseases 525
- Pharmacology 138
- Epidemiology 548
- Clinical Biochemistry 105
Countries citing papers authored by Qingqing Wang
This map shows the geographic impact of Qingqing Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingqing Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingqing Wang more than expected).
Fields of papers citing papers by Qingqing Wang
This network shows the impact of papers produced by Qingqing Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingqing Wang. The network helps show where Qingqing Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Qingqing Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Microbiological Diagnostic Performance of Metagenomic Next-generation Sequencing When Applied to Clinical Practice Hit paper breakdown → | 2018 | 602 |
| 2 | D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study Hit paper breakdown → | 2020 | 409 |
| 3 | 2012 | 170 | |
| 4 | 2019 | 44 | |
| 5 | 2019 | 32 | |
| 6 | 2023 | 25 | |
| 7 | 2016 | 25 | |
| 8 | 2020 | 23 | |
| 9 | 2022 | 16 | |
| 10 | Preparation and brain delivery of nasal solid lipid nanoparticles of quetiapine fumarate in situ gel in rat model of schizophrenia. | 2015 | 16 |
| 11 | 2018 | 14 | |
| 12 | 2019 | 11 | |
| 13 | 2014 | 9 | |
| 14 | 2019 | 9 | |
| 15 | 2007 | 7 | |
| 16 | 2022 | 7 | |
| 17 | 2023 | 7 | |
| 18 | 2019 | 7 | |
| 19 | 2023 | 7 | |
| 20 | 2018 | 6 |
About Qingqing Wang
Qingqing Wang is a scholar working on Molecular Biology, Oncology, Surgery, Epidemiology and Infectious Diseases, having authored 46 papers that have together received 1.5k indexed citations. Recurring topics across this work include Immune Response and Inflammation (3 papers), Immune Cell Function and Interaction (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Ginkgo biloba and Cashew Applications (2 papers), Metal-Organic Frameworks: Synthesis and Applications (2 papers), Autophagy in Disease and Therapy (2 papers), Tuberculosis Research and Epidemiology (2 papers) and Genetic Neurodegenerative Diseases (2 papers). The work is most often cited by research in Microbiology (31 citations), Infectious Diseases (525 citations), Pharmacology (138 citations), Epidemiology (548 citations) and Clinical Biochemistry (105 citations). Qingqing Wang has collaborated with scholars based in China, United States and Czechia. Frequent co-authors include Yumeng Yao, Bijie Hu, Sisi Chen, Kai Liu, Qingfeng Shi, Kaihuan Yu, Xiang Chen, Zheyong Huang, Zhe Luo and Jiatian Cao. Their work appears in journals such as Acta Pharmacologica Sinica, Clinical Infectious Diseases, Frontiers in Immunology, Environmental Pollution and Annals of Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.